The landscape of dementia diagnosis has evolved significantly with the arrival of advanced biomarkers, which include amyloid PET scans, tau imaging, and blood-primarily based assessments which can detect Alzheimer's pathology many years ahead of symptoms emerge. Even though these technological innovations represent impressive development in being f